Sarepta Therapeutics, Inc. (LON:0L35)

Sarepta Therapeutics Revenue

Sarepta Therapeutics had revenue of $399.36M USD in the quarter ending September 30, 2025, a decrease of -14.52%. This brings the company's revenue in the last twelve months to $2.41B, up 47.15% year-over-year. In the year 2024, Sarepta Therapeutics had annual revenue of $1.90B with 52.97% growth.

• Revenue (ttm): $2.41B
• Revenue Growth: +47.15%
• P/S Ratio: 0.92
• Revenue / Employee: $1.76M
• Employees: 1,372
• Market Cap: 1.66B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	658.64M	52.97%
Dec 31, 2023	1.24B	310.32M	33.26%
Dec 31, 2022	933.01M	231.13M	32.93%
Dec 31, 2021	701.89M	161.79M	29.96%
Dec 31, 2020	540.10M	159.27M	41.82%
Dec 31, 2019	380.83M	79.80M	26.51%
Dec 31, 2018	301.03M	146.45M	94.74%
Dec 31, 2017	154.58M	149.16M	2,751.58%
Dec 31, 2016	5.42M	4.17M	332.64%
Dec 31, 2015	1.25M	-8.50M	-87.16%
Dec 31, 2014	9.76M	-4.46M	-31.38%
Dec 31, 2013	14.22M	-23.11M	-61.91%
Dec 31, 2012	37.33M	-9.66M	-20.56%
Dec 31, 2011	46.99M	17.57M	59.72%
Dec 31, 2010	29.42M	11.84M	67.30%
Dec 31, 2009	17.59M	-3.67M	-17.28%
Dec 31, 2008	21.26M	10.27M	93.52%
Dec 31, 2007	10.99M	10.87M	9,428.06%
Dec 31, 2006	115.29K	-4.67M	-97.59%
Dec 31, 2005	4.78M	-	-